| Mitochondria as playmakers of apoptosis, autophagy and senescence M Abate, A Festa, M Falco, A Lombardi, A Luce, A Grimaldi, S Zappavigna, ... Seminars in cell & developmental biology 98, 139-153, 2020 | 480 | 2020 |
| Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time? I Cucinotto, L Fiorillo, S Gualtieri, M Arbitrio, D Ciliberto, N Staropoli, ... Journal of Drug Delivery 2013, 2013 | 107 | 2013 |
| Keratin 5 expression in squamocellular carcinoma of the head and neck V Vasca, E Vasca, P Freiman, D Marian, A Luce, M Mesolella, M Caraglia, ... Oncology Letters 8 (6), 2501-2504, 2014 | 102 | 2014 |
| Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid M Porru, S Zappavigna, G Salzano, A Luce, A Stoppacciaro, ... Oncotarget 5 (21), 10446, 2014 | 95 | 2014 |
| Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures CM Della Corte, G Barra, V Ciaramella, R Di Liello, G Vicidomini, ... Journal of Experimental & Clinical Cancer Research 38 (1), 1-12, 2019 | 81 | 2019 |
| Radiomics predicts survival of patients with advanced non‑small cell lung cancer undergoing PD‑1 blockade using Nivolumab V Nardone, P Tini, P Pastina, C Botta, A Reginelli, SF Carbone, ... Oncology Letters 19 (2), 1559-1566, 2020 | 70 | 2020 |
| Extracellular vesicles: new endogenous shuttles for miRNAs in cancer diagnosis and therapy? S Martellucci, NS Orefice, A Angelucci, A Luce, M Caraglia, S Zappavigna International Journal of Molecular Sciences 21 (18), 6486, 2020 | 61 | 2020 |
| Carcinogenetic mechanisms of endocrine disruptors in female cancers L Del Pup, A Mantovani, C Cavaliere, G Facchini, A Luce, P Sperlongano, ... Oncology reports 36 (2), 603-612, 2016 | 60 | 2016 |
| LncRNAs and immunity: coding the immune system with noncoding oligonucleotides M Bocchetti, M Scrima, F Melisi, A Luce, R Sperlongano, M Caraglia, ... International Journal of Molecular Sciences 22 (4), 1741, 2021 | 47 | 2021 |
| Transferrin-targeted nanoparticles containing zoledronic acid as a potential tool to inhibit glioblastoma growth G Salzano, S Zappavigna, A Luce, N D'Onofrio, ML Balestrieri, A Grimaldi, ... Journal of Biomedical Nanotechnology 12 (4), 811-830, 2016 | 45 | 2016 |
| Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience S Del Prete, M Caraglia, A Luce, L Montella, G Galizia, P Sperlongano, ... Oncology letters 18 (4), 3873-3879, 2019 | 43 | 2019 |
| MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer C Ferri, A Di Biase, M Bocchetti, S Zappavigna, S Wagner, P Le Vu, ... Journal of Experimental & Clinical Cancer Research 41 (1), 1-16, 2022 | 42 | 2022 |
| HLA expression correlates to the risk of immune checkpoint inhibitor-induced pneumonitis P Correale, RE Saladino, D Giannarelli, A Sergi, MA Mazzei, G Bianco, ... Cells 9 (9), 1964, 2020 | 42 | 2020 |
| The role of microRNAs in development of colitis-associated colorectal cancer M Bocchetti, MG Ferraro, F Ricciardiello, A Ottaiano, A Luce, AM Cossu, ... International Journal of Molecular Sciences 22 (8), 3967, 2021 | 40 | 2021 |
| Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer … P Correale, RE Saladino, D Giannarelli, R Giannicola, R Agostino, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 38 | 2020 |
| Insight toward the microRNA profiling of laryngeal cancers: biological role and clinical impact T Takeuchi, H Kawasaki, A Luce, AM Cossu, G Misso, M Scrima, ... International Journal of Molecular Sciences 21 (10), 3693, 2020 | 37 | 2020 |
| miR-125b upregulates miR-34a and sequentially activates stress adaption and cell death mechanisms in multiple myeloma G Misso, MR Zarone, A Lombardi, A Grimaldi, AM Cossu, C Ferri, ... Molecular Therapy-Nucleic Acids 16, 391-406, 2019 | 35 | 2019 |
| Endocrine disruptors and female cancer: Informing the patients L Del Pup, A Mantovani, A Luce, C Cavaliere, G Facchini, R Di Francia, ... Oncology reports 34 (1), 3-11, 2015 | 35 | 2015 |
| Urotensin‐II receptor is over‐expressed in colon cancer cell lines and in colon carcinoma in humans A Federico, S Zappavigna, M Romano, P Grieco, A Luce, M Marra, ... European journal of clinical investigation 44 (3), 285-294, 2014 | 35 | 2014 |
| Evolution of mutational landscape and tumor immune-microenvironment in liver oligo-metastatic colorectal cancer A Ottaiano, M Caraglia, A Di Mauro, G Botti, A Lombardi, J Galon, A Luce, ... Cancers 12 (10), 3073, 2020 | 34 | 2020 |
